Physician profile
Jennifer Oh
NPI 1407417942
$7,838.41
in general payments reported to CMS, 2019-2025
9 companies · $344 in 2025
The $344 reported for 2025 was more than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $362 · 2020: $1,060 · 2021: $660 · 2022: $1,386 · 2023: $1,847 · 2024: $2,180 · 2025: $344.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,403 · Travel and Lodging: $1,967.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,403.47 |
| Travel and Lodging | $1,966.60 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $3,241.42 | 2020-2025 | Precision 1, Total30, Dailies Total1 |
| Coopervision INC. | $1,502.83 | 2019-2023 | Cvi Contact Lens |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $1,263.85 | 2019-2021 | |
| Bausch & Lomb Americas INC. | $810.23 | 2022 | |
| Allergan, INC. | $369.85 | 2021-2022 | |
| Oyster Point Pharma, INC. | $234.71 | 2022 | |
| Sun Pharmaceutical Industries INC. | $165.33 | 2020-2022 | |
| Eyevance Pharmaceuticals LLC | $149.71 | 2021 | |
| Johnson & Johnson Vision Care, INC. | $100.48 | 2022-2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jennifer Oh listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.